Get VC-Level Feedback Without Knowing a Single VC
You have a startup idea, maybe traction, and no venture capitalist in your contacts. Cold emails to name-brand funds don't get replies. Founders with investor networks get feedback on decks, positioning, and ask before the partner meeting. Everyone else walks in blind, and a bad pitch burns a relationship that doesn't come back.
The gap isn't access to opinions. It's access to evidence. A founder can guess which slide is weakest, or test the specific claim behind it against real audience data before the meeting, not during it.
The claim that actually gets challenged
Every pitch deck rests on a handful of claims: how big the market is, what customers will pay, which feature matters most, how the company should be positioned against competitors. Partners don't push back on the deck's design. They push back on these claims, because a check depends on them.
An unproven claim in a partner meeting has two bad outcomes. Either it gets challenged on the spot and stalls momentum, or it goes unchallenged and the founder spends the next round of funding building toward a market that was never real. Testing the claim first avoids both.
Test the claim, not the room
Run a randomized experiment against the claim itself, instead of assembling opinions about how it will land. Subconscious runs controlled studies against a person-level audience graph covering 800 million real people. Point it at the specific claim in the deck, such as willingness to pay a given price or which feature matters most to a target buyer, and get back a causal estimate with a confidence interval instead of a founder's assertion.
That's a different kind of evidence than a simulated reaction. A confidence interval tells you how much the estimate could be wrong. A guess doesn't.
From simulated test to real people, same question
A causal estimate from an audience graph is often enough to walk into a meeting with a defensible number instead of a hunch. When the stakes justify it, the same question moves to real-human validation without changing what was tested. Subconscious can test or validate studies with real human participants: start simulated to see whether a claim is worth pursuing, then validate the promising ones with real people before it goes in the deck.
What this doesn't replace
This process tests a market claim. It does not simulate an individual investor, predict how a specific partner will react to your pitch, replace a warm introduction, or negotiate a term sheet. Venture decisions involve judgment about team, timing, and fit that a causal test of a market claim was never built to answer. Due diligence checklists cover categories like team, market, and terms. Treat causal testing as evidence for one of those categories, market, not a stand-in for the whole process.
It also won't tell you why a specific fund passed. Founders who've collected the real reasons behind VC rejections report that vague feedback is common and the actual reason is often narrower than "not a fit." A tested market claim narrows what you have to guess about; it doesn't eliminate the judgment calls investors make about the rest of the deal.
Which claim to test first
Before the next pitch, pick the single claim most likely to get challenged and put a number behind it:
- Demand size: how many target buyers actually have the problem you're solving
- Price tolerance: what the target buyer will actually pay, not what you assumed
- Feature priority: which capability the buyer values most when forced to trade off
- Positioning: how the buyer ranks you against the alternative they'd otherwise choose
Each of these can be run as a controlled causal test rather than argued from a founder's instinct. Test the specific claim that's weakest in the current deck, then bring the estimate and its confidence interval into the room. Learn how the tests work or see a walkthrough.